CL2016000998A1 - Composición herbaria, procedimiento para su preparación y uso de la misma - Google Patents

Composición herbaria, procedimiento para su preparación y uso de la misma

Info

Publication number
CL2016000998A1
CL2016000998A1 CL2016000998A CL2016000998A CL2016000998A1 CL 2016000998 A1 CL2016000998 A1 CL 2016000998A1 CL 2016000998 A CL2016000998 A CL 2016000998A CL 2016000998 A CL2016000998 A CL 2016000998A CL 2016000998 A1 CL2016000998 A1 CL 2016000998A1
Authority
CL
Chile
Prior art keywords
procedure
preparation
herbal composition
herbal
composition
Prior art date
Application number
CL2016000998A
Other languages
English (en)
Inventor
Swati Ajay Piramal
Ashish Chandrakant Suthar
Rahul Ramesh Shelar
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of CL2016000998A1 publication Critical patent/CL2016000998A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CL2016000998A 2013-10-28 2016-04-27 Composición herbaria, procedimiento para su preparación y uso de la misma CL2016000998A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361896321P 2013-10-28 2013-10-28

Publications (1)

Publication Number Publication Date
CL2016000998A1 true CL2016000998A1 (es) 2017-01-20

Family

ID=53003431

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016000998A CL2016000998A1 (es) 2013-10-28 2016-04-27 Composición herbaria, procedimiento para su preparación y uso de la misma

Country Status (13)

Country Link
US (1) US20160296577A1 (es)
EP (1) EP3062803A4 (es)
JP (1) JP2016535746A (es)
KR (1) KR20160066558A (es)
CN (1) CN105682670A (es)
AU (1) AU2014343262A1 (es)
CA (1) CA2928542A1 (es)
CL (1) CL2016000998A1 (es)
IL (1) IL245296A0 (es)
MX (1) MX2016005576A (es)
PH (1) PH12016500775A1 (es)
RU (1) RU2016120665A (es)
WO (1) WO2015063674A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105054253A (zh) * 2015-07-27 2015-11-18 广西鹿寨方田贸易有限公司 罗汉果烘干方法
US10675319B2 (en) 2016-06-21 2020-06-09 Tci Co., Ltd. Method for regulating circadian clock, regulating diurnal preference, adjusting a biological clock, improving sleep quality and/or facilitating sleep by using momordica charantia extract
IT201700002235A1 (it) * 2017-06-07 2018-12-07 Arche Frama Srls Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere
KR20200027551A (ko) 2017-07-11 2020-03-12 화이자 인코포레이티드 Cea muc1 및 tert를 포함하는 면역원성 조성물
CN110376294B (zh) * 2019-05-28 2021-07-23 神威药业集团有限公司 一种瓜蒌配方颗粒指纹图谱的构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183747B1 (en) * 1999-07-14 2001-02-06 Kaijun Ren Use of plant Momordica charactia extracts for treatment of acne acid
UA112174C2 (uk) * 2011-01-28 2016-08-10 Пірамал Ентерпрайзіс Лімітед Спосіб одержання трав'яного екстракту
CN103284083B (zh) * 2012-02-24 2016-06-08 中科云健康科技(天津)有限公司 高维生素c含量的苦瓜干品及其制备方法

Also Published As

Publication number Publication date
RU2016120665A3 (es) 2018-06-09
EP3062803A4 (en) 2017-05-03
PH12016500775A1 (en) 2016-05-30
JP2016535746A (ja) 2016-11-17
RU2016120665A (ru) 2017-12-01
KR20160066558A (ko) 2016-06-10
EP3062803A1 (en) 2016-09-07
WO2015063674A1 (en) 2015-05-07
IL245296A0 (en) 2016-06-30
AU2014343262A1 (en) 2016-06-02
CN105682670A (zh) 2016-06-15
US20160296577A1 (en) 2016-10-13
CA2928542A1 (en) 2015-05-07
MX2016005576A (es) 2016-12-09

Similar Documents

Publication Publication Date Title
CL2016000685A1 (es) Material para protección balística, su método de preparación y uso.
CO6831975A2 (es) Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso
BR112014031262A2 (pt) composições biocatalisadoras inovadoras e processos para uso.
CL2016002364A1 (es) Indazol-3-carboxamidas 5-sustituidas y preparación y uso de las mismas
BR112016000489A2 (pt) composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos
BR112015023310A2 (pt) composições, métodos e kits para redução de níveis lipídicos
BR112015030525A2 (pt) nanopartícula, kit, método de preparação de uma nanopartícula, e uso da nanopartícula
BR112015015758A2 (pt) dispersão sólida, formulação sólida, método de preparo de uma dispersão sólida, preparação farmacêutica e uso de uma dispersão sólida
BR112015002091A2 (pt) método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição
BR112015022167A2 (pt) dispositivos, sistemas e métodos para preparação de amostras
ZA201509307B (en) Pharmaceutical composition, preparation and uses thereof
DK2966079T3 (da) Pyridopyrimidin eller pyridopyrimidinforbindelse, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf
HUE056434T2 (hu) Glikozaminoglikán vegyület, annak elõállítása és alkalmazása
BR112015016548A2 (pt) polimixinas , composições , métodos de preparação e métodos de uso
BR112014026873A2 (pt) método cosmético, composição cosmética e uso.
HRP20181663T1 (hr) Priprema (s,s)-sekoizolaricirezinol diglukozida i (r,r)-sekoizolaricirezinol diglukozida
CR20140362A (es) Fenilimidazopirazoles sustituidos y su uso
BR112015027026A8 (pt) composição para uso na redução da formação de casca e na promoção da cicatrização
CL2016000998A1 (es) Composición herbaria, procedimiento para su preparación y uso de la misma
CL2015002110A1 (es) Parvovirus porcino 5b, métodos de uso y vacuna
DK3011965T3 (da) Salvia miltiorrhiza-ekstrakt, mikropelletformulering deraf, fremgangsmåder til fremstilling af samme, og anvendelsen deraf
EP2950646A4 (en) AGROCHEMICAL COMPOSITION, PROCESS FOR PREPARATION AND USE THEREOF
BR112014027027A2 (pt) composição cosmética, método cosmético e uso de uma combinação.
CO7061074A2 (es) Composiciones de liberación controlada y métodos para su uso
BR112015021722A2 (pt) composição para uso no tratamento de síndrome do ovário policístico